FDA Inspection
Patheon Biologics B.V.Patheon Biologics B.V. – FDA Inspection, Nov 9, 2021
Record Details
This FDA Inspection record concerns Patheon Biologics B.V., with an inspection on November 9, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Patheon Biologics B.V.
- Inspection Date
- November 9, 2021
- Product Type
- Drugs
View Company Profile
ID · f36b975f-2f0a-43f2-84d1-df7b0c0d0138
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1206906
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Patheon Biologics B.V.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 28, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2018 | Not classified | Office of Inspections and Investigations | |
| November 14, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 9, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Patheon Biologics B.V.
- FDA Inspection 1204968 - 2023-03-28
- FDA Inspection 1051335 - 2018-02-13
- FDA Inspection 903359 - 2014-11-14
- FDA Inspection 678752 - 2010-07-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.